The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy
The current article describes the need for combination therapy to achieve and maintain glycemic control in patients with T2DM and describes the role of combination therapy containing sulfonylureas (SUs), which may be particularly valuable in resource-limited settings.
(PDF) Consensus Recommendations on Sulfonylurea and ...
For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy . Focus on newer drugs ...
NICE guidance
Furthermore, visual representations like the one above help us fully grasp the concept of Sulfonylurea Combination Therapy.
NICE guidance on insulin therapy with oral agents in type 2 diabetes covers starting basal or pre-mixed regimens and continuing metformin, with cautious use of sulfonylurea or pioglitazone.
Md F, Orabi A, et al. Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus
Type 2 diabetes
Alternatively, if dual therapy is unsuccessful, it may be appropriate to start insulin-based treatment—see Drug treatment, insulin. Elderly patients or those with renal impairment are at particular risk of hypoglycaemia; if a sulfonylurea is indicated, a shorter-acting sulfonylurea , such as gliclazide or tolbutamide should be prescribed.
Introduction Metformin is the initial oral antihyperglycemic agent (OHA) of choice for most patients with type 2 diabetes (T2D). However, more than one agent is often required for optimal glucose control. As the choice of preferred second OHAs is less well defined, we sought to compare the real-world safety of sulfonylureas to other OHAs as add-on therapy to metformin in patients with T2D ...
Metformin and sulphonylurea combination therapy for adults ...
The combination of metformin plus sulphonylurea is widely used. We wanted to investigate the effects of metformin plus sulphonylurea on patient-important outcomes such as complications of diabetes (for example kidney and eye disease, heart attacks, strokes), death from any cause, health-related quality of life and side effects of the medications.
Sulfonylureas , Prescribing information, Diabetes - type 2, CKS Possible drug interactions associated with sulfonylureas include: Beta-blockers — the warning signs of hypoglycaemia (such as tremor) may be masked when a sulfonylurea is given with a beta-blocker. Colesevelam — the absorption of glibenclamide, glimepiride, and glipizide may be reduced by colesevelam. The manufacturer of ...
More Context About Sulfonylurea Combination Therapy
(PDF) rs622342 in SLC22A1, CYP2C9*2 and CYP2C9*3 and Glycemic Response. For Sulfonylurea Combination Therapy, this point helps readers notice the most relevant visual details before moving into the gallery.
Liraglutide mono- and sulfonylurea combination therapies in Japanese. It gives the article a little more context before the image collection begins.
(PDF) Combination Therapy With Insulin and Sulfonylureas for Type II. The extra context helps the page feel more useful without forcing the same phrase repeatedly.
